[Department of Error] Department of Error

Castaigne S, Pautas C, Terr é C, et al. Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study. Lancet 2012; 379: 1508–16—In table 1 of this Article, the Intermediate row under the Cytogenetics heading has been updated. This c orrection has been made to the online version as of Feb 8, 2018.
Source: LANCET - Category: General Medicine Tags: Department of Error Source Type: research